Koh C S, Kwaan H C, Paterson P Y
Northwestern University, Department of Microbiology-Immunology, Medical School, Chicago, IL 60611.
J Neuroimmunol. 1990 Aug;28(3):189-200. doi: 10.1016/0165-5728(90)90012-c.
Fibrinolytic activity in the form of plasminogen activator (PA) was assessed using a histochemical fibrin slide technique in spinal cords of normal Lewis rats and rats with the cell-transferred form of experimental allergic encephalomyelitis (EAE). PA was localized exclusively to blood vessels. Vessels in the leptomeninges had maximum activity. A precipitous decrease in PA activity occurred in recipient rats which coincided with onset of clinical neurologic signs. A subsequent return in activity occurred in association with clinical remission of disease but remained well below the activity level of normal rats for as long as the recipient animals were followed. Vessels containing perivascular cellular infiltrates of EAE had little or no detectable PA activity. Furthermore, PA could not be demonstrated to be associated with infiltrating inflammatory cells, including macrophages. These findings provide further support for involvement of the coagulation and fibrinolytic systems in the early clinical manifestations of EAE in Lewis rats.
采用组织化学纤维蛋白玻片技术,在正常Lewis大鼠和患有细胞转移型实验性变态反应性脑脊髓炎(EAE)的大鼠脊髓中评估纤溶酶原激活剂(PA)形式的纤溶活性。PA仅定位于血管。软脑膜中的血管活性最高。受体大鼠的PA活性急剧下降,这与临床神经体征的出现同时发生。随后,随着疾病的临床缓解,活性恢复,但在随访受体动物的过程中,其活性水平一直远低于正常大鼠。含有EAE血管周围细胞浸润的血管几乎没有或检测不到PA活性。此外,未证明PA与包括巨噬细胞在内的浸润性炎症细胞有关。这些发现为凝血和纤溶系统参与Lewis大鼠EAE的早期临床表现提供了进一步的支持。